MS

Martin E. Sanders

IT Io Therapeutics: 49 patents #2 of 19Top 15%
University Of Texas System: 3 patents #1,041 of 6,559Top 20%
DC Dartmouth College: 2 patents #180 of 689Top 30%
US US Dept of Health & Human Services: 2 patents #591 of 3,044Top 20%
CP Celtrix Pharmaceuticals: 2 patents #21 of 42Top 50%
DC Diatex Co.: 1 patents #15 of 25Top 60%
Stanford University: 1 patents #2,251 of 5,197Top 45%
TC The University Of Chicago: 1 patents #530 of 1,377Top 40%
IB Igm Biosciences: 1 patents #14 of 16Top 90%
ME Metabolex: 1 patents #34 of 50Top 70%
📍 Spring, TX: #17 of 2,039 inventorsTop 1%
🗺 Texas: #1,264 of 125,132 inventorsTop 2%
Overall (All Time): #40,081 of 4,157,543Top 1%
59
Patents All Time

Issued Patents All Time

Showing 26–50 of 59 patents

Patent #TitleCo-InventorsDate
10874628 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2020-12-29
10874627 Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2020-12-29
10874694 RAR selective agonists in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2020-12-29
10857117 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2020-12-08
10842764 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2020-11-24
10835507 Treatment of muscular disorders with combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2020-11-17
10806713 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2020-10-20
10702489 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2020-07-07
10695312 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2020-06-30
10653650 Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists Roshantha A. Chandraratna, Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2020-05-19
10588881 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2020-03-17
10532074 RAR selective agonists in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2020-01-14
10532073 RAR selective agonists in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2020-01-14
10517843 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2019-12-31
10485778 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2019-11-26
10485775 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2019-11-26
10471030 Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2019-11-12
10363272 RAR selective agonists in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2019-07-30
10278932 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2019-05-07
10231944 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2019-03-19
10213401 Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2019-02-26
10123982 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2018-11-13
10092535 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2018-10-09
10004708 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2018-06-26
10004709 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2018-06-26